Optimizing patient-provider communication in patients with amyloidosis using a virtual platform
Amyloidosis is a group of rare diseases characterized by insoluble, extracellular protein (amyloid) deposition in various organs leading to organ dysfunction and failure. A total of 36 amyloidogenic proteins have been identified; 17 of these may go on to cause…